Doctor profile · Federal record

Dr. Katherine Furmanski, APRN

Family Nurse Practitioner (CMS: Nurse Practitioner) · Registered Nurse · Franklin, TN

  • NPI 1831368414
  • Accepts Medicare
  • MIPS 75.1 / 100 · 2023
  • 20 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
Vanderbilt Health and Wiliamson Medical Center Clinics, 919 Murfreesboro Road
Franklin, TN 370643002
(615) 936-6046
fax (615) 322-5048
Mailing address
3841 Green Hills Village Dr Ste 200
Nashville, TN 372152691

Credentials & registration

NPPES · NUCC
NPI registered
February 2008 — 18 yrs on file
Profile last updated
March 29, 2022
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State licenses (2)
Tennessee #APN0000012328 · Tennessee #RN0000109832

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1831368414. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
632
Distinct HCPCS
9
Medicare allowed
$42,665
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 226 211 $99
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 102 34 $0
87636 Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b 100 97 $134
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) 76 74 $16
94640 Inhalation treatment for airway obstruction or sputum production 34 34 $7
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test 29 27 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 27 27 $72
99215 Established patient office or other outpatient visit, 40-54 minutes 24 24 $137
96372 Injection of drug or substance under skin or into muscle 14 14 $11

In context: peer comparison

Among 26 peers in this city , average services per provider: 274. This provider delivers 2.3× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$24
Transactions
1
Manufacturers
1
Payer (manufacturer) Industry Txns Amount
Abbott Laboratories 1 $23.59

By nature of payment

Food and Beverage
$24

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
330
Patients
301
Total drug cost
$4,088
Drug Type Claims Patients Total cost
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 45 35 $1,296
Doxycycline Hyclate Generic 44 43 $463
Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) Brand 38 38 $308
Nitrofurantoin Mono-Macro (Nitrofurantoin Monohyd/M-Cryst) Brand 38 38 $518
Fluticasone Propionate Generic 23 18 $470
Doxycycline Monohydrate Generic 20 20 $287
Azithromycin Generic 18 18 $107
Prednisone Generic 16 16 $34
Amoxicillin Generic 15 15 $47
Methylprednisolone Generic 15 15 $97

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Katherine Furmanski's medical specialty?
Dr. Katherine Furmanski practices Family Nurse Practitioner in Franklin, TN.
Where does Dr. Katherine Furmanski practice?
Dr. Katherine Furmanski practices at Vanderbilt Health and Wiliamson Medical Center Clinics, Franklin, TN 370643002. Office phone: 6159366046.
What is Dr. Katherine Furmanski's NPI?
Dr. Katherine Furmanski's National Provider Identifier (NPI) is 1831368414, issued by NPPES.
Does Dr. Katherine Furmanski accept Medicare assignment?
Yes. Dr. Katherine Furmanski accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Katherine Furmanski commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS J7613); Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS 87636). Source: CMS Medicare Physician & Other Practitioners file.